Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
  1. 4 Option exercise EVP, Chief Development Officer acquired 3,875 shares (option exercise)
  2. 4 Option exercise EVP, Chief Financial Officer acquired 3,875 shares (option exercise)
  3. 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
  4. 4 Grant or award Director acquired 37,879 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Option exercise EVP, Chief Development Officer acquired 11,694 shares (option exercise)
  7. 4 Option exercise EVP, Chief Financial Officer acquired 11,694 shares (option exercise)
  8. 4 Option exercise Chief Executive Officer acquired 34,789 shares (option exercise)
  9. 4 Option exercise EVP, Chief Development Officer acquired 3,874 shares (option exercise)
  10. 4 Option exercise EVP, Chief Financial Officer acquired 3,874 shares (option exercise)
  11. 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
  12. 4 Conversion 10% owner acquired 946,100 shares (conversion)
  13. 4 Open-market buy 10% owner bought 2,387,225 shares at $1.50 ($3,580,838)
  14. 4 Open-market buy Director bought 1,766,546 shares at $1.50 ($2,649,819)
  15. 4 Option exercise EVP, Chief Development Officer acquired 11,695 shares (option exercise)
  16. 4 Option exercise EVP, Chief Financial Officer acquired 11,695 shares (option exercise)
  17. 4 Option exercise Chief Executive Officer acquired 34,789 shares (option exercise)
  18. 4 Option exercise EVP, Chief Development Officer acquired 3,874 shares (option exercise)
  19. 4 Option exercise EVP, Chief Financial Officer acquired 3,874 shares (option exercise)
  20. 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)

Page 3 of 30 · 585 filings